(0.07%) 5 473.15 points
(0.12%) 39 157 points
(0.37%) 17 783 points
(0.10%) $80.91
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.23%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.67%) $10.67
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments...
Stats | |
---|---|
今日成交量 | 0 |
平均成交量 | 747 281 |
市值 | 156.51M |
EPS | $-0.840 ( Q3 | 2022-11-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.89 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.459 (6.45%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-08 | Kayitalire Louis | Sell | 29 236 | Common Stock |
2023-03-08 | Kayitalire Louis | Sell | 25 019 | Common Stock |
2023-03-08 | Kayitalire Louis | Sell | 27 289 | Stock Option (right to buy) |
2023-03-08 | Kayitalire Louis | Sell | 12 880 | Stock Option (right to buy) |
2023-03-08 | Kayitalire Louis | Sell | 53 634 | Stock Option (right to buy) |
INSIDER POWER |
---|
-97.82 |
Last 100 transactions |
Buy: 1 523 682 | Sell: 2 468 516 |
音量 相关性
F-star Therapeutics, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
F-star Therapeutics, Inc. 相关性 - 货币/商品
F-star Therapeutics, Inc. 财务报表
Annual | 2021 |
营收: | $21.17M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.517 |
FY | 2021 |
营收: | $21.17M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.517 |
FY | 2020 |
营收: | $11.26M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-9.69 |
FY | 2019 |
营收: | $28.32M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-2.54 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company\'s principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。